“A LEAP 2 conclusions? Targeting the ghrelin system to treat obesity and diabetes”

by Deepali Gupta, Sean B. Ogden, Kripa Shankar, Salil Varshney, Jeffrey M. Zigman
Published 2021-04-01

LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue

by Kripa Shankar, Nathan P. Metzger, Omprakash Singh, Bharath K. Mani, Sherri Osborne-Lawrence, Salil Varshney, Deepali Gupta, Sean B. Ogden, Shota Takemi, Corine P. Richard, Karabi Nandy, Chen Liu, Jeffrey M. Zigman
Published 2021-11-01

Rohitukine inhibits in vitro adipogenesis arresting mitotic clonal expansion and improves dyslipidemia in vivo[S]

by Salil Varshney, Kripa Shankar, Muheeb Beg, Vishal M. Balaramnavar, Sunil Kumar Mishra, Pankaj Jagdale, Shishir Srivastava, Yashpal S. Chhonker, Vijai Lakshmi, Bhushan P. Chaudhari, Rabi Shankar Bhatta, Anil Kumar Saxena, Anil Nilkanth Gaikwad
Published 2014-06-01

Disrupting the ghrelin-growth hormone axis limits ghrelin's orexigenic but not glucoregulatory actions

by Deepali Gupta, Anna M. Patterson, Sherri Osborne-Lawrence, Angie L. Bookout, Salil Varshney, Kripa Shankar, Omprakash Singh, Nathan P. Metzger, Corine P. Richard, Steven C. Wyler, Joel K. Elmquist, Jeffrey M. Zigman
Published 2021-11-01